Astellas Pharma: Clinical Trials & Research Profile
Biopharma Industry (Tokyo, JP / Northbrook, IL) · Primary Focus: Oncology and Hematology
| Clinical Trial Metric | Verified Public Record |
|---|---|
| Organization Type | Consolidated Trial Sponsor |
| Institutional Sector & Location | Biopharma Industry (Tokyo, JP / Northbrook, IL) |
| Primary Therapeutic Area | Oncology and Hematology |
| Active Phase II & III Studies | 28 active (15 recruiting now) |
| Total Tracked Studies (2018 to 2026) | 63 (31 with California sites) |
| Completed vs Early-Stopped Studies | 28 completed / 7 stopped (11.1% stop rate) |
| Median Closed Enrollment | 149 participants |
| FDA Drugs@FDA Original Approvals | 27 all-time (8 from 2018 to 2026) |
| Physical Hospital Site Disclosure | 100.0% named hospital slots |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for Astellas Pharma across sibling Meru public-data platforms.
Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk